Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB Cause Intercepted product administration error? 5 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Intercepted product administration error have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.

5
Reports of Intercepted product administration error with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
0
Deaths
1
Hospitalizations

How Dangerous Is Intercepted product administration error From ADALIMUMAB?

Of the 5 reports, 1 (20.0%) required hospitalization.

Is Intercepted product administration error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Intercepted product administration error?

EVOLOCUMAB (2,508) DENOSUMAB (1,209) ERENUMAB-AOOE (1,015) ETANERCEPT (574) DARBEPOETIN ALFA (385) PEGFILGRASTIM (356) LEUPROLIDE (307) ERYTHROPOIETIN (301) ROMOSOZUMAB-AQQG (115) BENZYL ALCOHOL\ETANERCEPT (112)

Which ADALIMUMAB Alternatives Have Lower Intercepted product administration error Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

Related Pages

ADALIMUMAB Full Profile All Intercepted product administration error Reports All Drugs Causing Intercepted product administration error ADALIMUMAB Demographics